Streetbeat News

Analyst Ratings

X

United States Steel (NYSE:X) has received 6 indifferent analyst ratings in the last quarter, with an average price target of $26.5, implying an upside from the current price of $21.64. The average price target has decreased by 14.52% from the previous average of $31.00.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 6:03 pm

GLBE

In the last quarter, Global E Online (NASDAQ:GLBE) received 12 bullish analyst ratings with an average 12-month price target of $40.08, up 19.21% from the previous average of $33.62.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 6:02 pm

FBRT

In the last 3 months, 4 analysts have offered 12-month price targets for Franklin BSP Realty Trust (NYSE:FBRT), with an average price target of $14.38, a 4.13% decrease from the previous average price target of $15.00.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 6:01 pm

RCKT

Rocket Pharmaceuticals (NASDAQ:RCKT) has received 6 bullish and 1 somewhat bullish ratings from analysts in the last quarter, with an average price target of $57.0, up 6.2% from the previous average of $53.67. The current price of RCKT is $22.39.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:09 pm

NGVT

Over the past 3 months, 7 analysts have published their opinion on Ingevity (NYSE:NGVT) stock, with an average price target of $74.57, implying upside from the current price of $52.29. The current average has decreased by 12.85% from the previous average price target of $85.57.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:08 pm

PNTG

In the last quarter, Pennant Gr (NASDAQ:PNTG) received 1 bullish, 2 somewhat bullish, and 3 indifferent analyst ratings. The average price target is $15.17, representing an upside from the current price of $12.775. The current average price target is a 2.76% decrease from the previous average of $15.60.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:07 pm

GOOGL

In the last quarter, Alphabet (NASDAQ:GOOGL) received 21 bullish and 1 indifferent analyst ratings, with an average 12-month price target of $128.14, up 2.26% from the previous average of $125.31.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:05 pm

IMVT

HC Wainwright & Co. has maintained its Buy rating for Immunovant (NASDAQ:IMVT) and raised its price target from $26.00 to $27.00. Shares of Immunovant are currently trading down 3.77% at $22.86 per share.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:04 pm

CLF

In the last quarter, Cleveland-Cliffs (NYSE:CLF) received 2 somewhat bullish and 2 indifferent analyst ratings. The company has an average 12-month price target of $19.0, a 24.0% decrease from the previous average of $25.00.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:04 pm

RBT

Canaccord Genuity has maintained its Buy rating for Rubicon Technologies (NYSE:RBT) but lowered its price target from $4.00 to $3.00. Rubicon Technologies' shares are currently trading down 13.04% at $0.60 per share.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 5:03 pm